Global Coalition on Aging (GCOA) Launches Cross-Sector Alliance Committed to Health Innovation at High-Level Forum on The Silver Economy

Alliance for Health Innovation Brings Patient, Policy, Academic, Industry & Global Health Stakeholders Together to Drive Solutions that Support a Thriving Innovation Sector & Healthy Aging 

November 8, 2022 (New York, NY) – Today, the Global Coalition on Aging (GCOA), along with cross-sector stakeholders representing patient advocacy, policy, industry, and academic communities, announced the launch of the Alliance for Health Innovation at the High-Level Forum on the Silver Economy in New York. The Alliance is dedicated to establishing the importance of innovation in achieving healthy aging and health equity through investments, policy reforms, and strategic partnerships. GCOA announced the Alliance during a panel discussion at the High-Level Forum featuring patient advocacy organizations, HIV and healthcare equity organizations, biopharmaceutical companies, and more.

“GCOA is committed to bringing stakeholders from across the global health spectrum together to advance innovation that benefits all populations, which requires a broad array of partnerships and communities to confront the complex health challenges that come with population aging,” said Michael Hodin, CEO of the Global Coalition on Aging (GCOA) and convener of the Alliance for Health Innovation. “The Alliance will play a central role in advocating for policy reforms and solutions that enable the robust and thriving innovation sector to support healthy aging, advance health equity, and ensure that people can live healthier and longer lives.”

With the next decade defined by healthy aging, the Alliance is focused on advancing policies that reimagine and reshape aging in the 21st century. Policy priorities of the Alliance include:

  • Spending on Health Innovation as an Investment
  • Re-imagine 21st Century Aging and Health Needs
  • Ensure an Access Framework is Judged by Health Equity Metrics Based on Innovation
  • Emphasize the Role of Care Delivery to All Societies
  • Encourage Strong Intellectual Property Protections

“Innovation drives the development, advancement, and discovery of medical products, treatments, and technologies necessary to achieve health equity and support healthy aging,” said Sue Peschin, President and CEO of the Alliance for Aging Research, and a founding member. “The work of the Alliance for Health Innovation will ensure that health equity and healthy aging are front and center in conversations about the value of innovation to patients.”

Today, our world faces an urgent challenge – providing quality care to the rapidly growing population of older adults. The COVID-19 pandemic, like the HIV epidemic, highlight the seriousness of existing gaps in systems and programs. Government policies that enable patients to access the best care and most effective life-changing medicines are critically important in protecting against disparities related to aging and longevity,” said Rekha Ramesh, Vice President, Head of Global Policy at Gilead Sciences, Inc., a founding member of the Alliance. “At Gilead, it is our mission to deliver innovative therapies that positively impact outcomes for patients everywhere, and we are proud to join members of the Alliance in helping inform policy solutions to ensure those who need our therapies receive them in support of healthy aging.”

“To achieve healthy aging, we must improve patient access to innovative treatments for communicable diseases such as HIV which bear a disproportionate impact on historically underserved populations,” said Scott Bertani, Director of Advocacy at HealthHIV, a founding member of the Alliance. “This collaboration of cross-sector leaders will share new ideas to address equity, access, and affordability issues that persist in our healthcare system.”

The launch of the Alliance at this year’s High-Level Forum on the Silver Economy underscores the group’s recognition that aging populations can be drivers of productivity and wealth creation by remaining active, engaged, and working. The Alliance welcomes the perspective and engagement of stakeholders across the spectrum to support and advance solutions that drive innovation and better outcomes for aging populations.

About the Global Coalition on Aging

The Global Coalition on Aging (GCOA) aims to reshape how global leaders approach and prepare for the 21st century’s profound shift in population aging. Through research, public policy analysis, advocacy and strategic communications, GCOA is advancing innovative policy and market solutions and working to ensure global aging is a path to health, productivity, and economic growth.

About the High-Level Forum on The Silver Economy

The Silver Economy Forum 2022 launches new ideas and explores unique collaborations and discoveries that impact healthy aging for older people, and everyone. SEF 2022 focuses on the policies and practices required to leverage the potential of the $17 trillion Silver Economy and the potential investment opportunities of the market.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.

Menopause, the Silver Economy and Workplace Opportunities

As we recognise World Menopause Day, take a moment to consider the economic power, diverse expertise and skills, and incredible societal contributions of the estimated 1.1 billion post-menopausal women worldwide by 2025—a population on-par with China or India, and dwarfing any other country. Indeed, if we want to fuel the vibrant $15 trillion silver economy, societies, governments, and employers must empower older women in the future of work, including solutions that fight stigma and increase workplace support related to menopause.

Best Practices for Engaging a Multigenerational Workforce

Employers are grappling with a myriad of workforce-related issues ranging from productivity to attracting and retaining talent, but many may be overlooking some seismic shifts that are reshaping the future of work: longevity, population aging, and the multigenerational workforce.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.